Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-Chemical properties and coatings

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Sakulkhu, Usawadee ^a   Mahmoudi, Morteza ^b   Maurizi, Lionel ^a   Salaklang, Jatuporn ^a   Hofmann, Heinrich ^a  

^a EPFL   (Switzerland)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FERRIC ION; FERRIC OXIDE; MAGNETITE NANOPARTICLE; PLASMA PROTEIN; POLYMER;

ANIMAL; CHEMISTRY; FEMALE; LEWIS RAT; RAT;

ANIMALS; BLOOD PROTEINS; CONTRAST MEDIA; FEMALE; FERRIC COMPOUNDS; MAGNETITE NANOPARTICLES; POLYMERS; RATS; RATS, INBRED LEW;

EID: 84901236286     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05020     Document Type: Article

References (53)

1. Cedervall, T. et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew. Chem. Int. Ed. Engl. 46, 5754-5756 (2007). (Pubitemid 47172204)
2. Cedervall, T. et al.Understanding the nanoparticle-protein corona usingmethods to quantify exchange rates and affinities of proteins for nanoparticles. PNAS 104, 2050-2055 (2007). (Pubitemid 46391350)
3. Mahmoudi, M., Hofmann, H., Rothen-Rutishauser, B. & Petri-Fink, A. Assessing the In Vitro and In Vivo Toxicity of Superparamagnetic Iron Oxide Nanoparticles. Chem. Rev. 112, 2323-2338 (2012).
4. Monopoli, M. P. et al. Physical2Chemical Aspects of Protein Corona: Relevance to in Vitro and in Vivo Biological Impacts of Nanoparticles. J. Am. Chem. Soc. 133, 2525-2534 (2011).
5. Mahmoudi, M. et al. Protein-nanoparticle interactions: opportunities and challenges. Chem. Rev. 111, 5610-5637 (2011).
6. Walczyk, D., Bombelli, F. B.,Monopoli, M. P., Lynch, I.& Dawson, K. A. What the Cell 'Sees' in Bionanoscience. J. Am. Chem. Soc. 132, 5761-5768 (2010).
7. Hellstrand, E. et al. Complete high-density lipoproteins in nanoparticle corona. FEBS Journal 276, 3372-3381 (2009).
8. Lindman, S. et al. Systematic Investigation of the Thermodynamics of HSA Adsorption to N-iso-Propylacrylamide/N-tert-Butylacrylamide Copolymer Nanoparticles. Effects of Particle Size and Hydrophobicity. Nano Lett. 7, 914-920 (2007). (Pubitemid 46717733)
9. Linse, S. et al. Nucleation of protein fibrillation by nanoparticles. PNAS 104, 8691-8696 (2007). (Pubitemid 47175373)
10. Lundqvist, M. et al.Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. PNAS 105, 14265-14270 (2008).
11. Lynch, I. & Dawson, K. A. Protein-nanoparticle interactions. Nano Today 3, 40-47 (2008). (Pubitemid 351298587)
12. Lynch, I., Dawson, K. A. & Linse, S. Detecting Cryptic Epitopes Created by Nanoparticles. Sci. STKE 2006, pe14 (2006).
13. Lynch, I. et al. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv. Colloid Interface Sci. 134-135, 167-174 (2007). (Pubitemid 47614904)
14. Dawson, K. A., Salvati, A. & Lynch, I. Nanotoxicology: Nanoparticles reconstruct lipids. Nat. Nanotechnol. 4, 84-85 (2009).
15. Monopoli, M. P., Bombelli, F. B. & Dawson, K. A. Nanobiotechnology: nanoparticle coronas take shape. Nat. Nanotechnol. 6, 11-12 (2011).
16. Rosen, J. E., Chan, L., Shieh,D.-B.& Gu, F. X. Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine: Nanotechnology, Biology Med. 8, 275-290 (2012).
17. Mahmoudi, M., Sant, S., Wang, B., Laurent, S. & Sen, T. Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy. Adv. Drug Delivery Rev. 63, 24-46 (2011).
18. Laurent, S., Dutz, S., Häfeli, U. O. & Mahmoudi,M.Magnetic fluid hyperthermia: Focus on superparamagnetic iron oxide nanoparticles. Adv. Colloid Interface Sci. 166, 8-23 (2011).
19. Ang, D., Tay, C. Y., Tan, L. P., Preiser, P. R. & Ramanujan, R. V. In vitro studies of magnetically enhanced transfection in COS-7 cells. Mat. Sci. Eng. C 31, 1445-1457 (2011).
20. Soenen, S. J., De Smedt, S. C. & Braeckmans, K. Limitations and caveats of magnetic cell labeling using transfection agent complexed iron oxide nanoparticles. Contrast Med. Mol. Imag. 7, 140-152 (2012).
21. Mahmoudi, M. et al.Magnetic Resonance Imaging Tracking of Stem Cells in Vivo Using Iron Oxide Nanoparticles as a Tool for the Advancement of Clinical Regenerative Medicine. Chem. Rev. 111, 253-280 (2011).
22. Mahmoudi, M., Simchi, A., Milani, A. S. & Stroeve, P. Cell toxicity of superparamagnetic iron oxide nanoparticles. J. Colloid Interface Sci. 336, 510-518 (2009).
23. Neuwelt, E. A. et al. Delivery of virus-sized iron oxide particles to rodent CNS neurons. Neurosurgery 34, 777-784 (1994). (Pubitemid 24100560)
24. Müller, R. H., Maaben, S., Weyhers, H., Specht, F. & Lucks, J. S. Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. Int. J. Pharm. 138, 85-94 (1996). (Pubitemid 26241925)
25. Berry, C. C.,Wells, S., Charles, S., Aitchison, G. & Curtis, A. S. G. Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials 25, 5405-5413 (2004). (Pubitemid 38586755)
26. Berry, C. C., Wells, S., Charles, S. & Curtis, A. S. G. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 24, 4551-4557 (2003). (Pubitemid 37013615)
27. Gupta, A. K., Berry, C., Gupta, M. & Curtis, A. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis. IEEE Trans Nanobiosci. 2, 255-261 (2003).
28. Gupta, A. K. & Curtis, A. S. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors. Biomaterials 25, 3029-3040 (2004). (Pubitemid 38210195)
29. Gupta, A. K., Naregalkar, R. R., Vaidya, V. D. & Gupta, M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2, 23-39 (2007). (Pubitemid 46845774)
30. Gupta, A. K. & Wells, S. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobiosci. 3, 66-73 (2004).
31. van den Bos, E. J. et al. Improved Efficacy of Stem Cell Labeling for Magnetic Resonance Imaging Studies by the Use of Cationic Liposomes. Cell Transplant. 12, 743-756 (2003). (Pubitemid 37409742)
32. Laurent, S., Burtea, C., Thirifays, C., Rezaee, F. & Mahmoudi, M. Significance of cell 'observer' and protein source in nanobiosciences. J. Colloid Interface Sci. 392, 431-445 (2013).
33. Maiorano, G. et al. Effects of Cell Culture Media on the Dynamic Formation of Protein2Nanoparticle Complexes and Influence on the Cellular Response. ACS Nano 4, 7481-7491 (2010).
34. Mahmoudi, M. et al. Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. Nanoscale 3, 1127-1138 (2011).
35. Steitz, B. et al. Fixed Bed Reactor for Solid-Phase Surface Derivatization of Superparamagnetic Nanoparticles. Bioconjugate Chem. 18, 1684-1690 (2007). (Pubitemid 47464081)
36. Salaklang, J. et al. Superparamagnetic Nanoparticles as a Powerful Systems Biology Characterization Tool in the Physiological Context. Angew. Chem. Int. Ed. 47, 7857-7860 (2008).
37. Prigent, P. et al. in Molecular and Cellular MR Imaging (Modo, M. & Bulte, J.) 59-83 (CRC Press, 2007).
38. Reinert, M. et al. Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study. Int. J. Nanomedicine 1793 (2011). doi:10.2147/ IJN.S23638.
39. Hofmann-Amtenbrink, M., Hofmann, H. & Montet, X. Superparamagnetic nanoparticles - a tool for early diagnostics. Swiss Med Wkly 140, w13081 (2010).
40. Jiang, Y. et al. In-vivo studies on intraperitoneally administrated poly(vinyl alcohol). J. Biomed. Mater. Res. Part B Appl. Biomater. 93, 275-284 (2010).
41. Venturoli, D. & Rippe, B. Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. Am. J. Physiol. Renal. Physiol. 288, F605-F613 (2005). (Pubitemid 40381726)
42. Dobrovolskaia, M. A. & McNeil, S. E. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2, 469-478 (2007). (Pubitemid 47220069)
43. Levy, M. et al. Long term in vivo biotransformation of iron oxide nanoparticles. Biomaterials 32, 3988-3999 (2011).
44. Mahmoudi, M., Shokrgozar, M. A. & Behzadi, S. Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles. Nanoscale 5, 3240-3244 (2013).
45. Lesniak, A. et al. Effects of the Presence or Absence of a Protein Corona on Silica Nanoparticle Uptake and Impact on Cells. ACS Nano 6, 5845-5857 (2012).
46. Puzyn, T. et al. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat. Nanotechnol. 6, 175-178 (2011).
47. Capriotti, A. L. et al.Do plasma proteins distinguish between liposomes of varying charge density? J. Proteomics 75, 1924-1932 (2012).
48. Lai, Z. W., Yan, Y., Caruso, F. & Nice, E. C. Emerging Techniques in Proteomics for Probing Nano-Bio Interactions. ACS Nano 6, 10438-10448 (2012).
49. Rauch, J., Kolch, W. & Mahmoudi, M. Cell Type-Specific Activation of AKT and ERK Signaling Pathways by Small Negatively-Charged Magnetic Nanoparticles. Sci. Rep. 2, (2012).
50. Park, J. et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat. Mater. 3, 891-895 (2004).
51. Mahmoudi, M. & Serpooshan, V. Silver-Coated Engineered Magnetic Nanoparticles Are Promising for the Success in the Fight against Antibacterial Resistance Threat. ACS Nano 6, 2656-2664 (2012).
52. Chastellain, M., Petri, A. & Hofmann, H. Particle size investigations of a multistep synthesis of PVA coated superparamagnetic nanoparticles. J. Colloid Interface Sci. 278, 353-360 (2004). (Pubitemid 39144384)
53. Maurizi, L., Sakulkhu, U., Gramoun, A., Vallee, J.-P. & Hofmann, H. A fast and reproducible method to quantify magnetic nanoparticle biodistribution. Analyst 139, 1184 (2014).